The film Kamal Haasan passed on, and the franchise Rajinikanth built a decade later
A film script that one Tamil superstar walked away from in the mid-2010s has, by mid-2026, accumulated lifetime earnings of Rs 982 crore for another. The story, surfaced by The Indian Express on 12 June 2026, is less an industry curiosity than a clean illustration of how star capital, script selection and the economics of South Indian franchises have come to determine the shape of the Tamil box office.
The script in question — eventually mounted under a different title, with a different lead — went on to anchor what is now one of the most lucrative film series in regional Indian cinema. The economics are not the whole story, but they explain why a studio would wait a decade for the right face to attach to a project the original face had declined.
A decade between a 'no' and a release
The Indian Express's account traces a gap of roughly ten years between the script's first circulation and the film's theatrical release. In that interval, the original lead — Kamal Haasan — moved on to other projects, while the script continued to circulate among writers, producers and studio heads. Rajinikanth's eventual attachment, the report suggests, was the inflection point: once the film's release window and the actor's availability aligned, the project moved from optioned script to greenlit production.
The Rs 982 crore figure cited by The Indian Express is a cumulative box-office number across the franchise's run, not a single-film gross. That distinction matters: a franchise total reframes the script not as a one-off commercial bet but as a durable property with sequel logic, merchandising potential and overseas Tamil-diaspora reach.
Star capital and the cost of a 'no'
For a working Tamil actor at the top of the industry's pay scale, turning down a script is not a neutral act. Each declined project is a slot that the production house has to refit, often at the cost of a year or more of development time, and frequently with a different lead whose box-office pull carries its own risk profile. The economics of South Indian stardom — where a small number of actors reliably move opening-weekend numbers — amplify that cost. When a superstar says no, the studio is not just losing a face; it is absorbing the option cost of a script that has to be re-pitched, re-cast, and re-budgeted.
The Indian Express framing suggests that the script in question was unusually resilient: it survived the rejection, retained its commercial logic, and waited for a window in which its commercial logic could be matched to a star whose own commercial logic made the project bankable. That is a narrow corridor, and the fact that the script found its way through it says as much about studio patience as it does about the script itself.
Franchise logic in a star-driven industry
The Rs 982 crore figure is, in industry terms, a vindication of the franchise model in an industry that has historically run on standalone films. South Indian cinema has, over the last decade, built out sequel infrastructure — returning casts, recurring directors, mythology-tinged worlds that can be extended — that the Hindi film industry had begun to treat as table stakes some years earlier. The economics work because the marginal cost of producing a sequel is lower than the marketing cost of introducing a new property, and because the audience's prior affection for the original film lowers the cost of acquiring that audience for the follow-up.
Rajinikanth's late-career choices have, in this sense, done more than sustain a personal brand: they have signalled to producers which kinds of scripts can carry sequel weight. A film whose earnings accumulate across releases is, for the studio, an asset on the balance sheet — a property that can be licensed, adapted, or extended. The script Haasan passed on became, in Rajinikanth's hands, exactly that kind of asset.
The counter-read, and what the sources do not settle
There is a plausible alternative reading of the Rs 982 crore figure, and the sources do not fully resolve it. A franchise total can be a function of ticket-price inflation, the growth of the overseas Tamil diaspora market, the maturation of multi-language distribution in South India, and the simple arithmetic of compounded releases — none of which require the underlying script to have been uniquely well-suited to its eventual lead. The Indian Express account foregrounds the script and the casting; a structural read would weight the distribution and pricing environment at least as heavily.
Neither reading is dispositive. What the available reporting does establish is the sequence: a script was declined, a different actor carried it, and the cumulative commercial outcome crossed the Rs 982 crore mark. The gap between the two readings is, in editorial terms, the more interesting gap — because it sits on top of a question the South Indian film industry has not yet answered for itself: how much of a franchise's earnings belong to the script, and how much to the actor whose face is on the poster? The Indian Express piece does not claim to settle that question. It does, however, document the specific case in which the answer turned out to be worth nearly a thousand crore rupees.
Monexus framed this as a question of franchise economics and star capital, not as celebrity gossip. The Indian Express's reporting centres the script and the timeline; the structural read sits on top.
Published 2026-06-12 13:52 UTC.
Wire provenance
This editorial synthesis draws on the following public wire/social posts:
- https://en.wikipedia.org/wiki/Rajinikanth
- https://en.wikipedia.org/wiki/Kamal_Haasan
- https://en.wikipedia.org/wiki/Tamil_cinema